ABOUT USA Bangor University Spin Out, Based On Leading Edge Technology
Established in 2015 as a Point of Care (PoC) diagnostics company to deliver unique devices for the diagnosis of Mycobacterial infections, utilising novel mycolic acid antigens.
Situated within M-SParc, a unique science park that brings together companies of all sizes. Encouraging both innovation and collaboration, within high-spec laboratories and a friendly environment.
CORE TECHNOLOGYFully Synthetic Mycolic Acids
Unique compounds that are potent and selective signalling agents in the immune system
Mycolic acids are unique to mycobacteria and responsible for many of their properties.
Synthetic mycolic acids and other cell wall components of mycobacteria are useful in a number of areas including:
- Diagnostic Testing
- Vaccine Adjuvants
- Prophylactic and therapeutic agents
- Asthma Treatment
- Anti-cancer Agents
OUR TEAMA small but dedicated team of scientists
Prof. Mark Baird
Managing Director
CHAIRMAN, IP MANAGERDr. Malcolm Jones
CHIEF COMMERCIAL OFFICERDr. Don Cardy
RESEARCH AND DEVELOPMENT SCIENTISTDr. Dafydd Thomas
RESEARCH AND DEVELOPMENT SCIENTISTAnna Cervi
RESEARCH AND DEVELOPMENT SCIENTISTPaul Mason
Company Reg. No: 07975264 VAT No: 215835607 © 2020 Diagnostig. All rights reserved